CanadaBuys #SK-UofSRFPCP-831974

GLP-Compliant Toxicology Study for PanSarb Vaccine Sought by University of Saskatchewan

The University of Saskatchewan is seeking qualified Contract Research Organizations (CROs) to conduct a Good Laboratory Practice (GLP) compliant repeat-dose toxicology study for the PanSarb vaccine. - Government buyer: - University of Saskatchewan, Procurement Office - Vendors and OEMs: - No specific OEMs or vendors are named; open to qualified CROs - Products/services requested: - GLP-compliant repeat-dose toxicology study - Study must support a Phase 1 (first-in-human) clinical trial application to Health Canada - Adherence to specifications and conditions outlined in the Request for Proposal (RFP) - Unique or notable requirements: - Strict GLP compliance - Alignment with Health Canada clinical trial application standards - Access to RFP and bidding managed via USask Bonfire electronic platform - Contract duration: - Estimated at 24 months

Description

The University of Saskatchewan is requesting proposals from qualified Contract Research Organizations (CRO) to conduct a Good Laboratory Practice (GLP) compliant repeat-dose toxicology study. This study supports a Phase 1 (first-in-human) clinical trial application to Health Canada. The study must adhere to the specifications and conditions outlined in the Request for Proposal documents. The contract duration is estimated to be 24 months, and the procurement method is competitive open bidding.

View original listing